Business Context and Reporting Period
This Form 8-K is a current report filed by Gardner Denver Holdings, Inc. on January 5, 2018, regarding events occurring on January 8, 2018. The filing addresses executive leadership changes within the company's Medical Group and related compensatory arrangements.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on personnel changes and equity compensation terms.
Material Changes
- Departure of Officer: Patrick W. Bennett stepped down as President of the Medical Group effective January 8, 2018, by mutual agreement.
- Transition Period: Mr. Bennett is expected to remain an employee through March 31, 2018, to assist with the transition.
- Compensatory Arrangements:
- Unvested stock options (58,389 time-based and 58,389 time- and performance-based) will remain outstanding and eligible to vest as if Mr. Bennett continued employment.
- The expiration date for vested stock options is extended to 9 months after the earlier of the fifth anniversary of July 30, 2013, or a Change of Control.
- Appointments: Amod Kher was appointed Vice President and General Manager of the Medical Group, and Robert Thikoll was appointed Senior Vice President.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, or management commentary on future performance. It notes that the press release regarding these appointments is furnished as Exhibit 99.1 and is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the specific terms of the Management Stockholder's Agreement (MSA) referenced regarding the option expiration extension.
- Confirm the operational impact of the leadership transition in the Medical Group via the press release (Exhibit 99.1).
- Monitor future filings for the appointment of a permanent successor to the Medical Group President role if Amod Kher's role is interim.